SEOUL, South Korea--(BUSINESS WIRE)--On 28 March, Gencurix (KONEX:229000) announced that the results of clinical trials for the prediction of breast cancer prognosis were published in Scientific ...

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc., a skin cancer diagnostics company providing personalized genomic information to improve cancer management decisions, today announced two ...

In the modern era of advanced imaging and genomics testing, the digital rectal exam (DRE) is still an "important" and clinically relevant prognostic test for prostate cancer, conclude the authors of a ...

Cancer is a leading cause of death worldwide, so there is an urgent need to define the molecular mechanisms driving the development and progression of individual tumors and identify a molecular ...

Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing Current guidelines for postoperative management of patients with stage I-IIA ...

Phoenix, AZ, December 8, 2004--The Molecular Profiling Institute (MPI), today announced that it is the sole source provider in the United States for MammaPrint®. MammaPrint® is a prognostic test ...

In this article, we will attempt to inform this debate by summarizing what is known about prognostic awareness (PA) in the adult advanced cancer and palliative care settings. We also review ...